US Patent Issued to Amicus Therapeutics on Sept. 16 for "Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene" (New Jersey Inventor)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,944, issued on Sept. 16, was assigned to Amicus Therapeutics Inc. (Philadelphia).

"Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene" was invented by Elfrida Benjamin (Millstone Township, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods of treating a patient diagnosed with Fabry disease and methods of enhancing Alpha-galactosidase A in a patient diagnosed with or suspected of having Fabry disease. Certain methods comprise administering to a patient a therapeutically effective dose of a pharmacological chaperone for Alpha-galactosidase A, wherein the patient has a splice site mutation in...